AU2018396512B2 - Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair - Google Patents

Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair Download PDF

Info

Publication number
AU2018396512B2
AU2018396512B2 AU2018396512A AU2018396512A AU2018396512B2 AU 2018396512 B2 AU2018396512 B2 AU 2018396512B2 AU 2018396512 A AU2018396512 A AU 2018396512A AU 2018396512 A AU2018396512 A AU 2018396512A AU 2018396512 B2 AU2018396512 B2 AU 2018396512B2
Authority
AU
Australia
Prior art keywords
milk
hair
acid
pharmaceutical composition
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018396512A
Other languages
English (en)
Other versions
AU2018396512A1 (en
Inventor
Hirotaro Fukuoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2018396512A1 publication Critical patent/AU2018396512A1/en
Application granted granted Critical
Publication of AU2018396512B2 publication Critical patent/AU2018396512B2/en
Priority to AU2024219679A priority Critical patent/AU2024219679B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2018396512A 2017-12-26 2018-12-26 Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair Active AU2018396512B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2024219679A AU2024219679B2 (en) 2017-12-26 2024-09-12 Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017249980 2017-12-26
JP2017-249980 2017-12-26
PCT/JP2018/047736 WO2019131712A1 (ja) 2017-12-26 2018-12-26 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2024219679A Division AU2024219679B2 (en) 2017-12-26 2024-09-12 Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair

Publications (2)

Publication Number Publication Date
AU2018396512A1 AU2018396512A1 (en) 2020-02-13
AU2018396512B2 true AU2018396512B2 (en) 2024-06-13

Family

ID=67067427

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018396512A Active AU2018396512B2 (en) 2017-12-26 2018-12-26 Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair

Country Status (12)

Country Link
US (3) US11413321B2 (enExample)
EP (1) EP3733173A4 (enExample)
JP (4) JP6628946B2 (enExample)
KR (2) KR20200102978A (enExample)
CN (2) CN119326743A (enExample)
AU (1) AU2018396512B2 (enExample)
BR (1) BR112020003022A2 (enExample)
CA (1) CA3070854A1 (enExample)
MX (2) MX2020001764A (enExample)
SG (1) SG11202000906YA (enExample)
TW (2) TW202308606A (enExample)
WO (1) WO2019131712A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6925072B1 (ja) 2020-12-07 2021-08-25 株式会社Dr.Cherry 毛髪改善のための組成物

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172410A (ja) * 1983-03-19 1984-09-29 Suntory Ltd 脂肪酸含有養毛組成物
EP0116439A3 (en) 1983-02-02 1986-01-29 Suntory Limited Fatty acid containing hair tonic composition
GB8603621D0 (en) * 1986-02-14 1986-03-19 Habib N Modifying lipid structure of cell membranes
GB9026664D0 (en) * 1990-12-07 1991-01-23 Unilever Plc Cosmetic composition
US5863938A (en) 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5663208A (en) 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
ES2102813T3 (es) * 1993-01-26 1997-08-01 Horse Vitality Ltd Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
IT1290347B1 (it) * 1997-02-18 1998-10-22 Horse Vitality Ltd Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento della caduta dei capelli
US6620427B2 (en) 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
EP1583512B3 (en) 2002-12-12 2012-12-05 R.B.T. (Rakuto Bio Technologies) Ltd. USE of LIGNIN PEROXIDASE IN SKIN AND HAIR LIGHTENING
CU23256A1 (es) 2003-03-20 2008-01-24 Dalmer Lab Sa EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS
TWI256893B (en) 2003-03-25 2006-06-21 Fancl Corp Composition for promoting production of type I collagen and/or elastin
DE602004029058D1 (de) * 2003-07-09 2010-10-21 Shinonogi & Co Ltd Inducer von atopischer dermatitis
JP2005179190A (ja) 2003-12-16 2005-07-07 Kao Corp 創傷治癒促進剤
KR101237316B1 (ko) 2004-05-21 2013-02-28 타다시 고이노 두피두발용 조성물
FR2872912B1 (fr) * 2004-07-09 2007-03-02 Centre Nat Rech Scient Cnrse Nouveau systeme microfluidique et procede de capture de cellules
FR2873293B1 (fr) 2004-07-21 2006-11-17 Cerep Sa Utilisation d'un acide gras pour la preparation d'une composition topique destinee a l'apaisement des reactions inflammatoires dues aux piqures d'hymenopteres a venin
EP2481389B1 (en) * 2004-12-24 2016-05-04 Dolphst Pty Ltd Formulations and treatments for trichology
DE102006053692A1 (de) * 2006-11-13 2007-08-23 Henkel Kgaa Oxidative Haarbehandlung mit verringerter Haarschädigung
WO2008147228A1 (en) * 2007-05-31 2008-12-04 Fonterra Corporate Research And Development Limited Treatment or prevention of bone conditions
WO2009149537A1 (en) * 2008-06-12 2009-12-17 Christine Allen Injectable polymer-lipid blend
NZ591037A (en) 2008-07-15 2013-02-22 Christopher Thanos Wound healing using choroid plexus secreted proteins
JP5436929B2 (ja) 2009-05-15 2014-03-05 花王株式会社 まつ毛用化粧料
WO2011039637A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
JP5348784B2 (ja) 2009-12-28 2013-11-20 株式会社 資生堂 化粧料
AU2011223730A1 (en) 2010-03-02 2012-10-18 Imagenetix, Inc. Compositions comprising myristic acid and uses thereof
JP5927506B2 (ja) * 2010-04-13 2016-06-01 レルマダ セラピューティクス、インク． １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
JP5534200B2 (ja) 2010-06-25 2014-06-25 ホーユー株式会社 薬剤評価方法
US20120129789A1 (en) 2010-11-18 2012-05-24 Steven Yoelin Compositions and methods for hair growth
US20120149775A1 (en) * 2010-11-29 2012-06-14 Shiseido Company, Ltd. Methods for preventing and improving skin elastic property loss
US20160256505A1 (en) * 2011-06-29 2016-09-08 Junwu Xing Fatty acid composition and plant extract and pharmaceutical preparation and application thereof
KR101918773B1 (ko) 2012-05-03 2018-11-14 박시향 군소 추출물을 유효성분으로 포함하는 두피 개선 및 탈모 방지용 조성물
BR112015001694A2 (pt) * 2012-07-27 2017-07-04 Khal Fardoussi Kassem uso de uma composição para a fabricação de um medicamento para tratamento de distúrbios cutâneos e/ou distúrbios de proliferação celular anormal; composição; e método para preparar uma composição farmacêutica
IN2015DN03069A (enExample) * 2012-09-14 2015-10-02 Miracle Fruit Oil L L C
US12414911B2 (en) 2012-09-14 2025-09-16 Miracle Fruit Oil L.L.C. Topical compositions and methods of use
JP2015537028A (ja) 2012-11-16 2015-12-24 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 皮膚修復のための組成物および方法
EP2735303A1 (en) * 2012-11-23 2014-05-28 Pilosciences Hair growth compositions and methods
JP6334211B2 (ja) * 2013-03-29 2018-05-30 株式会社コーセー 毛髪及び頭皮ケア組成物、及びその使用方法
AU2014375268B2 (en) * 2013-12-31 2019-11-14 Pb & B Sa Controlled release fatty acid compositions for use in body reconstruction and body-shaping
KR102122614B1 (ko) 2014-02-25 2020-06-12 박시향 테트라셀미스 테트라셀레의 추출물을 유효 성분으로 함유하는 두피 개선 및 탈모 방지용 조성물
KR102299276B1 (ko) 2014-07-16 2021-09-09 (주)아모레퍼시픽 납떼기콩 오일을 포함하는 조성물
US10631973B2 (en) * 2014-11-14 2020-04-28 Washington University Compostions and methods for tissue repair
TW201722464A (zh) 2015-11-10 2017-07-01 波麥堤克生化科學有限公司 用於傷口癒合之纖維蛋白溶酶原給藥方案
GB201519923D0 (en) * 2015-11-11 2015-12-23 Biovotec Dac And Biovotec As Dry biocompatible disintegrateable films for delivering particulate egg shell membrane to a wound
WO2017146468A1 (ko) 2016-02-23 2017-08-31 경희대학교 산학협력단 줄기세포의 효능 개선을 위한 조성물 및 방법
JP6360944B2 (ja) 2016-05-26 2018-07-18 株式会社食健 皮膚外用剤及びその製造方法
CN106466327A (zh) 2016-11-01 2017-03-01 侯建生 臭氧化油在皮肤疾病、肥胖和静脉血栓防治中的应用
JP2024172410A (ja) 2023-05-31 2024-12-12 ダイヤゼブラ電機株式会社 トロイダルコイル固定構造

Also Published As

Publication number Publication date
US20250152649A1 (en) 2025-05-15
JP6732088B2 (ja) 2020-07-29
US20200246409A1 (en) 2020-08-06
JP2020128399A (ja) 2020-08-27
JP2020033370A (ja) 2020-03-05
US20220409688A1 (en) 2022-12-29
TW201929848A (zh) 2019-08-01
EP3733173A4 (en) 2021-10-27
US11413321B2 (en) 2022-08-16
CN119326743A (zh) 2025-01-21
CN111050763B (zh) 2024-10-11
EP3733173A1 (en) 2020-11-04
TWI787423B (zh) 2022-12-21
WO2019131712A1 (ja) 2019-07-04
MX2020001764A (es) 2020-07-29
KR20250058075A (ko) 2025-04-29
JP2020128400A (ja) 2020-08-27
BR112020003022A2 (pt) 2020-08-25
JP6731129B1 (ja) 2020-07-29
CN111050763A (zh) 2020-04-21
AU2024219679A1 (en) 2024-10-17
TW202308606A (zh) 2023-03-01
JP6628946B2 (ja) 2020-01-15
MX2022013816A (es) 2022-11-30
JPWO2019131712A1 (ja) 2019-12-26
SG11202000906YA (en) 2020-03-30
US12343369B2 (en) 2025-07-01
AU2018396512A1 (en) 2020-02-13
CA3070854A1 (en) 2019-07-04
KR20200102978A (ko) 2020-09-01
JP6765024B2 (ja) 2020-10-07

Similar Documents

Publication Publication Date Title
Bas et al. Electrode array-eluted dexamethasone protects against electrode insertion trauma induced hearing and hair cell losses, damage to neural elements, increases in impedance and fibrosis: a dose response study
US20100266532A1 (en) Methods for inhibiting scarring
Murillo-Cuesta et al. A comparative study of drug delivery methods targeted to the mouse inner ear: bullostomy versus transtympanic injection
US20250152649A1 (en) Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair
Wu et al. Transplantation of erythropoietin gene-modified neural stem cells improves the repair of injured spinal cord
US20220331367A1 (en) Pharmaceutical composition for use in improving quality of scalp or skin, wound healing, or improving quality of hair
HK40030380A (en) Pharmaceutical composition to be used for increasing hair, modifying scalp or skin, healing wounds, promoting osteogenesis, or modifying hair
AU2024219679B2 (en) Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair
CN115279394A (zh) 用于放射治疗的预防性皮肤治疗
CN107625781B (zh) miRNA抑制子在制备防治心肌梗死药物中的应用
EP4335447A1 (en) Agent for improving eye symptoms and method for improving eye symptoms
Xia et al. A Feasibility Research on Restoration of Demyelination in Trigeminal Nerve with Transnasal Administration of BDNF/NGF Loading on PEG-PLA Nanoparticles
ALOPECIA INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
WO2019237106A1 (en) Compositions and methods for treating stroke
Schwartzová Fascia Lata Graft of a Mucosa Disorder in Oral Cavity

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)